In 2013, the Kansas Legislature and Governor Sam Brownback approved the formation of the Midwest Stem Cell Therapy Center (MSCTC). The center is housed within the University of Kansas Medical Center (KUMC) campus in Kansas City, Kansas. The MSCTC is designed to serve as a hub of adult stem cell therapy, research, and education in the State of Kansas and the adjoining region.
The MSCTC faculty and staff include physicians, scientists, and trainees representing the fields of adult stem cell biology, neurology, oncology, hematology, cardiac and vascular, endocrine, and other sub-specialties. These individuals represent several local and regional institutions, enabling the formation of a stem cell network of knowledge and information. This synergy among various institutions also fosters productive collaborations that may result in faster translation of basic science discoveries into the clinic.
Through the support of our donors, the MSCTC has made significant strides in the relatively short time since its inception. Indeed, the MSCTC houses an FDA-registered GMP facility with the demonstrated capability to provide clinical grade adult stem cells for use in clinical trials. Several clinical trials with adult stem cells are in the start-up phase within KUMC and external research collaborations are being discussed. In addition, cutting edge molecular stem cell research is being conducted by MSCTC scientists. These ongoing studies involve induced pluripotent stem cells, regulation of cellular differentiation, cord blood cells, as well as various transcription factors and other molecular pathways in adult stem cells.
It is important to equip patients and caregivers alike with the latest information on adult stem cell therapy so they may make informed decisions regarding treatment options. For those who want to understand the very basics of adult stem cell therapy, check out our Adult Stem Cell Therapy 101 webpage, which we are continuing to grow. We have assembled a library of journal articles, organized by disease category. For patients who are interested in stem cell studies going on around the country, we have created a set of "ready-made" searches that automatically search ClinicalTrials.gov for the latest studies. In addition, the MSCTC is planning to expand the training of postdoctoral fellows in basic research in adult stem cell biology, as well as clinicians in adult stem cell-related topics.
We are getting ready for our third annual Midwest Conference on Cell Therapy and Regenerative Medicine this coming September. Open to the public, our annual conference been well received by a broad audience and has expanded to include internationally known leaders in stem cell research. We expect this annual meeting to continue to grow and be a key educational opportunity for the region, as well as an opportunity for global research leaders in this field.
While we have made great strides since our induction, we also understand that we are a very nascent center, and as such, have a long way to go. At the same time, we are excited by the support and enthusiasm surrounding the MSCTC and remain firmly committed to promoting adult stem cell therapy and research so that patients, with often incurable diseases, may have hope.
Thank you for visiting. We hope to count on your support toward improving lives with adult stem cells!
Buddhadeb Dawn, M.D.
Director, Midwest Stem Cell Therapy Center